NYSE:MDP Meredith (MDP) Stock Price, News & Analysis → The #1 Biotech Stock to Have on Your Radar in 2024… (From Huge Alerts) (Ad) Free MDP Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$58.04▼$59.0752-Week Range N/AVolume3.36 million shsAverage Volume552,848 shsMarket Capitalization$2.70 billionP/E Ratio10.01Dividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Meredith alerts: Email Address Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than BitcoinClick For My #1 FREE Crypto for 2024 About Meredith Stock (NYSE:MDP)Meredith Corp. engages in television broadcasting and magazine advertising business. It operates through the Local Media and National Media business segments. The Local Media segment includes television stations and offers websites, mobile-optimized websites, and mobile applications. The National Media segment consists of national consumer media brands delivered via multiple media platforms including print magazines and digital and mobile media, brand licensing activities, database-related activities, and business-to-business marketing products and services. The company was founded by Edwin Thomas Meredith in 1902 and is headquartered in Des Moines, IA.Read More Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than BitcoinClick For My #1 FREE Crypto for 2024 MDP Stock News HeadlinesNovember 8, 2023 | investorplace.comLegendary Investor Meredith Whitney Just Issued a Big Housing Market WarningJanuary 31, 2023 | finance.yahoo.comMedexus Pharmaceuticals Inc. (TSE:MDP): Are Analysts Optimistic?April 24, 2024 | Huge Alerts (Ad)The #1 Biotech Stock to Have on Your Radar in 2024… Revenues exploding, a $18.70 price target, and highly lucrative addressable markets make this one you cannot ignore!November 11, 2022 | finance.yahoo.comMedexus Pharmaceuticals Second Quarter 2023 Earnings: Beats ExpectationsNovember 8, 2022 | finance.yahoo.comMedexus Announces Strongest Quarter in Company History with Fiscal Q2 2023 Revenue of US$27.7 Million, a 55% Increase Over Fiscal Q2 2022October 6, 2022 | finance.yahoo.comMedexus Announces Preliminary Revenue Results for Second Fiscal Quarter 2023September 19, 2022 | finance.yahoo.comMedexus Provides Update on Treosulfan NDA Resubmission and Provides Business UpdateSeptember 15, 2022 | finance.yahoo.comMedexus Holds Annual Meeting of Shareholders and Announces Election of Board of DirectorsApril 24, 2024 | Huge Alerts (Ad)The #1 Biotech Stock to Have on Your Radar in 2024… Revenues exploding, a $18.70 price target, and highly lucrative addressable markets make this one you cannot ignore!August 17, 2022 | theglobeandmail.comMedexus Pharma MDP is in the bottom 25 performing stocks year-to-date on the Toronto Stock ExchangeAugust 9, 2022 | seekingalpha.comMedexus Pharmaceuticals Inc. (MEDXF) CEO Ken d'Entremont on Q1 2023 Results - Earnings Call TranscriptAugust 8, 2022 | finance.yahoo.comMedexus Announces Record Fiscal Q1 2023 Revenue of US$23.0 Million, a 33% Increase versus Fiscal Q1 2022November 23, 2021 | finance.yahoo.comMeredith Corporation Announces Winners of Good Impressions ProgramOctober 9, 2021 | benzinga.comWhat Does Meredith's Debt Look Like?October 8, 2021 | finance.yahoo.comSHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Meredith Corporation (NYSE - MDP)See More Headlines Receive MDP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Meredith and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings10/28/2021Today4/24/2024Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorConsumer Staples Industry Periodicals Sub-IndustryPublishing Current SymbolNYSE:MDP CUSIP58943310 CIK65011 Webwww.meredith.com Phone(515) 284-3000Fax515-284-2700Employees5,330Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$5.90 Trailing P/E Ratio10.01 Forward P/E RatioN/A P/E GrowthN/ANet Income$306.60 million Net Margins9.66% Pretax Margin13.12% Return on Equity41.72% Return on Assets4.92% Debt Debt-to-Equity Ratio4.03 Current Ratio1.39 Quick Ratio1.36 Sales & Book Value Annual Sales$2.98 billion Price / Sales0.00 Cash FlowN/A Price / Cash Flow5.68 Book Value$14.27 per share Price / BookN/AMiscellaneous Outstanding Shares45,781,000Free Float41,299,000Market Cap$2.70 billion OptionableOptionable Beta2.07 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesThomas H. HartyChairman, President & Chief Executive OfficerJason M. FrierottChief Financial & Accounting OfficerMichael BrownsteinChief Revenue Officer & Executive Vice PresidentSteven M. CappaertSenior Vice President & ControllerCharlie HenrichVice President & General ManagerKey CompetitorsGrocery OutletNASDAQ:GOJ&J Snack FoodsNASDAQ:JJSFUtz BrandsNYSE:UTZVestisNYSE:VSTSNewell BrandsNASDAQ:NWLView All Competitors MDP Stock Analysis - Frequently Asked Questions How were Meredith's earnings last quarter? Meredith Co. (NYSE:MDP) released its earnings results on Thursday, October, 28th. The company reported $0.86 EPS for the quarter, topping analysts' consensus estimates of $0.68 by $0.18. The company had revenue of $708.60 million for the quarter, compared to analysts' expectations of $681.84 million. Meredith had a trailing twelve-month return on equity of 41.72% and a net margin of 9.66%. The business's revenue for the quarter was up 2.2% compared to the same quarter last year. During the same period in the previous year, the business posted $1.04 EPS. What is Steve Lacy's approval rating as Meredith's CEO? 231 employees have rated Meredith Chief Executive Officer Steve Lacy on Glassdoor.com. Steve Lacy has an approval rating of 78% among the company's employees. What other stocks do shareholders of Meredith own? Based on aggregate information from My MarketBeat watchlists, some companies that other Meredith investors own include AT&T (T), Verizon Communications (VZ), AbbVie (ABBV), Exxon Mobil (XOM), Cisco Systems (CSCO), Chevron (CVX), Energy Transfer (ET), Pfizer (PFE), Gilead Sciences (GILD) and Altria Group (MO). This page (NYSE:MDP) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Meredith Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.